The Hidden Cause of Food Intolerance (It’s Not the Food)
Why It Matters
Identifying sucrase‑isomaltase deficiency and applying the SSRD diet can transform treatment of chronic food‑intolerance symptoms, delivering a cost‑effective, non‑pharmacologic solution for millions of sufferers.
Key Takeaways
- •Sucrase-isomaltase deficiency may affect 8‑25% of the people.
- •Symptoms mimic food intolerance: bloating, reflux, joint pain, skin eruptions.
- •SSRD diet targets this deficiency and rivals top gut‑healing protocols.
- •Diet also helps fungal, bacterial overgrowth, leaky gut, microbiota imbalance.
- •Michael Ruscio, MD, presents evidence and practical steps for implementation.
Summary
The video spotlights sucrase‑isomaltase (SI) deficiency—a genetic enzyme shortfall that can masquerade as classic food intolerance, triggering bloating, reflux, joint pain, skin eruptions, and other systemic complaints. Dr. Michael Ruscio explains that as many as 8‑25% of the population may carry this deficiency, yet most clinicians overlook it when evaluating digestive distress.
Ruscio outlines the Specific Carbohydrate Restriction Diet (SSRD) as a targeted therapeutic approach. Clinical comparisons show SSRD performing on par with, or surpassing, leading gut‑healing protocols such as the low‑FODMAP and Specific Carbohydrate diets. By eliminating complex sugars that require SI for digestion, the diet reduces fermentative by‑products, alleviating symptoms and supporting microbial balance.
A key quote from Ruscio emphasizes, “If you’re dealing with unexplained gut pain, the SSRD might be the most effective single diet for gut health.” He also notes secondary benefits: the regimen curtails fungal overgrowth, bacterial dysbiosis, leaky gut, and broader microbiota imbalances, offering a holistic gut‑repair strategy.
The implications are two‑fold. First, practitioners should consider screening for SI deficiency in patients with refractory food‑related symptoms. Second, patients can adopt the SSRD as a low‑risk, evidence‑backed intervention, potentially reducing reliance on pharmaceuticals and opening new market opportunities for specialized nutrition programs.
Comments
Want to join the conversation?
Loading comments...